Oxford tech transfer chief: ‘It’s been the most intense year’

In an exclusive interview, Adam Stoten of Oxford University Innovation explains why his team partnered with AstraZeneca on a COVID vaccine – and what made the deal unique
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: